Fingerprint
Dive into the research topics of 'Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study
Nizar M. Tannir, Daniel C. Cho, Adi Diab, Mario Sznol, Mehmet A. Bilen, Arjun V. Balar, Giovanni Grignani, Erika Puente, Lily Tang, David Chien, Ute Hoch, Arkopal Choudhury, Danni Yu, Sue L. Currie, Mary A. Tagliaferri, Jonathan Zalevsky, Arlene O. Siefker-Radtke, Michael E. Hurwitz
Research output: Contribution to journal › Article › peer-review
10
Scopus
citations